Today's Wall Street Journal has a (front page in the print edition) article that nicely summarizes some cases of a "Worrisome Ailment in Medicine: Misleading Journal Articles." It includes such cases as the controlled trial of Celebrex that included only six-month data (when the twelve-month data failed to show a benefit). As Jeffrey Drazen, editor of the New England Journal of Medicine put it, editors have "found themselves playing a game of hide-and-seek," including "experiences where authors tried to pitch it, where they were telling you the good news and not the bad."
(NB: the link above should work without requiring a subscription.)
FDA Approves New Noninvasive FFR Technology - The FDA said today that it had granted approval to a novel technology that noninvasively measures fractional flow reserve (FFR) using data obtained from a ...
2 hours ago